Teva Pharmaceutical Industries ADR (TEVA) Stock Price, Quote & News

Company Profile

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 972 3 914 8213

Website: www.tevapharm.com

Address:

124 Dvora HaNevi’a St., Tel Aviv-Yafo, Israel

Terrordomo80 Mar. 21 at 3:11 AM

$TEVA Could you imagine being this dotard right now having not taken any profit between 34 and 37 after waiting half a century...#Dopewiser

0 · Reply

Brruh Mar. 19 at 6:37 AM

$NVO dead money for many years. Don't feel too comfortable even if you bought at 40, one bad unexpected news and it goes below 30. Look at $TEVA , was the largest Israeli company and one of the biggest pharma in the world. When the patents expired and competitors and compounders started eating its market share, traded 90% from ath a few years ago and now down "only" 60%

1 · Reply

SdotRayborn Mar. 17 at 6:45 PM

$TEVA just don’t fill the gap for once hahah ya never know

1 · Reply

Smoka416 Mar. 17 at 5:58 PM

$TEVA just jumped back in at 30 will keep averaging down. This company is basically the best "generics brand" in the world they manufacture a ton of generic medications and sell them at a lower cost. Love this over $NVO $LLY

0 · Reply

Hopewisper Mar. 17 at 4:48 PM

$TEVA Terrorrooster saw 24 ... did you?

0 · Reply

Buy_SoFi Mar. 17 at 1:57 PM

$TLTFF <---- Keep an eye on this one $GILD $IBRX $MRK $TEVA HSV treatment far superior to current Acyclovir. NMIBC cure very competitive with Anktiva (Ruvidar)

1 · Reply

TeresaTrades Mar. 17 at 1:32 PM

Largest PUT OI increases $HUN $NVDA $SOFI $ORCL $TEVA

1 · Reply

TeresaTrades Mar. 17 at 1:29 PM

Largest CALL OI increases $SOFI $INTC $TEVA $SMCI $GRAB

0 · Reply

OfficialStocktwitsUser Mar. 16 at 11:47 PM

$TEVA RSI: 25.00, MACD: -1.0132 Vol: 1.87, MA20: 32.44, MA50: 32.81 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Ro_Patel Mar. 16 at 9:58 PM

Today's option volume of 65.8M contracts was -4.00% below recent avg levels, w/ calls leading puts 8 to 7. Index & ETF products saw relatively heavy volume, while single stock flow was moderate w/ 30.5M contracts traded on 4.3M trades Today's most active sectors included Industrials, Financials, & Consumer Cyclicals, while Energy & Telecommunications were relatively light. Among the 500 most liquid single stocks, 30day IV was higher for 82 & lower for 375. Unusual total option volume was observed in $TSM $NBIS $NOK $ADBE & $TEVA

0 · Reply

Insider Sell: Mark Sabag Sells 62,102 Shares of Teva Pharmaceutical Industries Ltd (TEVA)

Thu, 19 Mar 2026 16:30:00 -0400 - 2 days ago

Teva Releases Q1 2026 Aide Memoire

Thu, 19 Mar 2026 16:30:00 -0400 - 2 days ago

Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026

2026-03-10T17:00:23.000Z - 11 days ago

Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference Transcript

Tue, 10 Mar 2026 10:30:17 -0400 - 11 days ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mon, 09 Mar 2026 16:28:02 -0400 - 12 days ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Leerink Global Healthcare Conference 2026 Transcript

Fri, 06 Mar 2026 14:00:00 -0500 - 15 days ago

The 3 Best Stocks to Invest $1,000 in Right Now

2026-03-05T08:57:00.000Z - 16 days ago

Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's

2026-03-04T18:47:00.000Z - 17 days ago

Forget Teva: This Dividend Top Dog Is the Real Value Buy Today

2026-03-04T14:42:00.000Z - 17 days ago

3 Generic Drug Stocks to Watch Despite Industry Headwinds

2026-03-04T14:04:23.000Z - 17 days ago

Piper Sandler Updates Analyst Rating on TEVA, Raises Price Target | TEVA Stock News

Wed, 04 Mar 2026 04:06:00 -0500 - 17 days ago

Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding

2026-03-04T06:11:03.000Z - 18 days ago

Teva: Blackstone Life Sciences To Provide $400 Mln To Support Development Of Duvakitug

2026-03-03T22:58:10.000Z - 18 days ago

Teva Pharmaceutical (TEVA) Secures $400M Funding for Duvakitug Development

2026-03-03T22:28:17.000Z - 18 days ago

Blackstone (BX) Commits $400M to Teva for Duvakitug Development

2026-03-03T16:10:02.000Z - 18 days ago

Teva Pharmaceutical Industries Ltd (TEVA) Shares Gap Down to $32.22 on Mar 3

Tue, 03 Mar 2026 10:18:00 -0500 - 18 days ago

Baron Health Care Fund Q4 2025 Contributors And Detractors

2026-03-02T22:03:41.000Z - 19 days ago

Eliyahu Kalif Sells 345,810 Shares of Teva Pharmaceutical Industries Ltd (TEVA)

Mon, 02 Mar 2026 15:00:00 -0500 - 19 days ago

The Best Healthcare Stock to Invest $1,000 in Right Now

2026-03-02T13:00:31.000Z - 19 days ago

What's Driving the Market Sentiment Around Teva Pharmaceutical Industries Ltd?

Fri, 27 Feb 2026 18:22:00 -0500 - 22 days ago

Here's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole

Thu, 26 Feb 2026 19:05:00 -0500 - 23 days ago

Allspring Smid Cap Growth Fund Q4 2025 Top Contributors And Detractors

Feb 24, 2026, 4:30 PM EST - 25 days ago

Teva to Present at the Upcoming Investor Conferences in March

TEVA

2026-02-23T13:48:16.000Z - 26 days ago

FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application

2026-02-21T14:55:21.000Z - 4 weeks ago

Teva (TEVA) Advances Schizophrenia Treatment with FDA Application

2026-02-21T06:31:14.000Z - 4 weeks ago

FDA Accepts NDA For Teva And Medincell's Olanzapine LAI In Schizophrenia Treatment

2026-02-20T20:25:33.000Z - 4 weeks ago

Teva (TEVA) Gains FDA Nod for Schizophrenia Treatment Application

Feb 20, 2026, 2:43 PM EST - 4 weeks ago

U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

TEVA

2026-02-20T15:00:36.000Z - 4 weeks ago

Price Over Earnings Overview: Teva Pharmaceutical Indus

Fri, 20 Feb 2026 00:45:00 -0500 - 4 weeks ago

Allspring Mid Cap Growth Fund Q4 2025 Performance Insights, Portfolio Drivers & Decisions

2026-02-19T16:48:26.000Z - 4 weeks ago

Corcept Therapeutics Stock Plunges As Court Clears Teva Generic

Tue, 17 Feb 2026 10:54:57 -0500 - 4 weeks ago

Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript

Feb 17, 2026, 7:04 AM EST - 4 weeks ago

Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients

TEVA

Feb 17, 2026, 6:00 AM EST - 4 weeks ago

Teva and Sanofi's duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn's disease

TEVA

Wed, 28 Jan 2026 14:02:19 -0500 - 7 weeks ago

Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript

Jan 28, 2026, 12:22 PM EST - 7 weeks ago

Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook

TEVA

Jan 28, 2026, 7:31 AM EST - 7 weeks ago

Teva Pharmaceutical profit, revenue rise in fourth quarter

TEVA

Jan 28, 2026, 7:00 AM EST - 7 weeks ago

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential

TEVA

Jan 27, 2026, 8:00 AM EST - 7 weeks ago

Will Forte Teams Up with Teva to Get Real About Huntington's Disease with ‘Honestly HD'

TEVA

Jan 14, 2026, 5:02 PM EST - 2 months ago

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

TEVA

Wed, 14 Jan 2026 08:01:32 -0500 - 2 months ago

Teva Is No Longer A Turnaround Story, It's A Growth One

Tue, 13 Jan 2026 14:46:05 -0500 - 2 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 12:26 PM EST - 2 months ago

Teva Taps Royalty Pharma For $500M To Advance Skin Disease Drug

RPRX TEVA

Jan 12, 2026, 10:46 AM EST - 2 months ago

Why Investors Are So Optimistic on Teva

TEVA

Jan 11, 2026, 6:00 PM EST - 2 months ago

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

TEVA

Jan 11, 2026, 5:00 PM EST - 2 months ago

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

TEVA

Jan 5, 2026, 4:30 PM EST - 2 months ago

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference

TEVA

Jan 2, 2026, 8:58 AM EST - 2 months ago

Top 2 Health Care Stocks That May Crash In Q1

EXAS TEVA

Sat, 27 Dec 2025 14:03:31 -0500 - 3 months ago

Why a $34 Million Teva Stock Position Signals Confidence in a Long Repair Story

Dec 24, 2025, 8:36 AM EST - 3 months ago

S&P Global Ratings Upgrades Teva to ‘BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive

TEVA

Dec 23, 2025, 6:08 PM EST - 3 months ago

Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)

Dec 19, 2025, 3:40 AM EST - 3 months ago

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

Dec 9, 2025, 8:00 AM EST - 3 months ago

Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Dec 4, 2025, 2:08 PM EST - 3 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 25, 2025, 8:10 AM EST - 4 months ago

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

Nov 21, 2025, 4:30 PM EST - 4 months ago

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December

Nov 19, 2025, 8:07 AM EST - 4 months ago

Teva seeks startups to help solve global pharmaceutical challenges

Nov 18, 2025, 8:58 AM EST - 4 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 14, 2025, 10:38 AM EST - 4 months ago

Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business

Nov 10, 2025, 2:51 PM EST - 4 months ago

Teva Pharmaceutical Industries Limited (TEVA) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 7, 2025, 6:00 PM EST - 4 months ago

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Nov 5, 2025, 1:02 PM EST - 4 months ago

Teva Pharmaceuticals CEO on earnings beat: Our shift to biopharma is working

Nov 5, 2025, 1:01 PM EST - 4 months ago

Teva Pharmaceutical Industries Limited (TEVA) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 11:30 AM EST - 4 months ago

Teva Pharma's Key Branded Drugs Fuel Strong Revenue Growth, Lifts Full-Year Profit Outlook

Nov 5, 2025, 9:14 AM EST - 4 months ago

Teva Pharmaceuticals stock surges 12% as branded drug sales outperform

Nov 5, 2025, 7:44 AM EST - 4 months ago

Teva Pharm third-quarter profit tops estimates as branded drugs gain

Nov 5, 2025, 7:00 AM EST - 4 months ago

Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

Oct 31, 2025, 4:30 PM EDT - 5 months ago

Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November

Oct 30, 2025, 11:45 AM EDT - 5 months ago

Blood pressure medicine recalled over high levels of cancer-causing chemical

Oct 20, 2025, 4:30 PM EDT - 5 months ago

Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe

Oct 17, 2025, 12:18 PM EDT - 5 months ago

Teva Vs. Viatris: Who Will Dominate In President Trump's America?

VTRS

Oct 10, 2025, 3:00 PM EDT - 5 months ago

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

Oct 7, 2025, 4:07 AM EDT - 5 months ago

Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside

Terrordomo80 Mar. 21 at 3:11 AM

$TEVA Could you imagine being this dotard right now having not taken any profit between 34 and 37 after waiting half a century...#Dopewiser

0 · Reply

Brruh Mar. 19 at 6:37 AM

1 · Reply

SdotRayborn Mar. 17 at 6:45 PM

$TEVA just don’t fill the gap for once hahah ya never know

1 · Reply

Smoka416 Mar. 17 at 5:58 PM

0 · Reply

Hopewisper Mar. 17 at 4:48 PM

$TEVA Terrorrooster saw 24 ... did you?

0 · Reply

Buy_SoFi Mar. 17 at 1:57 PM

$TLTFF <---- Keep an eye on this one $GILD $IBRX $MRK $TEVA HSV treatment far superior to current Acyclovir. NMIBC cure very competitive with Anktiva (Ruvidar)

1 · Reply

TeresaTrades Mar. 17 at 1:32 PM

Largest PUT OI increases $HUN $NVDA $SOFI $ORCL $TEVA

1 · Reply

TeresaTrades Mar. 17 at 1:29 PM

Largest CALL OI increases $SOFI $INTC $TEVA $SMCI $GRAB

0 · Reply

OfficialStocktwitsUser Mar. 16 at 11:47 PM

0 · Reply

Ro_Patel Mar. 16 at 9:58 PM

0 · Reply

Tevaforme Mar. 16 at 9:55 PM

$TEVA We’re back on track, folks. Bought more options last week. I see new highs later this year.

0 · Reply

Contrarian_Dan Mar. 16 at 3:47 PM

$TEVA Averaged way up with 250 more shares. See you at $50

1 · Reply

Bazzzigar Mar. 15 at 12:46 PM

$TEVA better buy after War

0 · Reply

SdotRayborn Mar. 14 at 12:47 PM

$TEVA at this point come on down to the gap 🤞. I’m buying 2028 leaps if/when that happens. Also look at the same leaps on Pfizer, you would think Teva prices would be similar but it’s not even close. 👀. Teva actin a little different than usual and it’s being priced that way I feel. Wouldn’t mind a gap fill but also wouldn’t be surprised nowadays with the diff movement if it bounces back with force we are not used to seeing after the usual bleed toward the gap. Opinions welcomed.

0 · Reply

Terrordomo80 Mar. 14 at 1:59 AM

$TEVA He's riding the Schvantz...off 10% alone since this post...16% over the past mo.

1 · Reply

Hopewisper Mar. 13 at 11:01 PM

$TEVA Do you know how terror and dooster roosters child looks .....

0 · Reply

Bazzzigar Mar. 13 at 8:50 PM

$TEVA join with HIMS

0 · Reply

Makingmillions192 Mar. 13 at 6:55 PM

$LEXX Our MTA partner is of great importance to us but is not our only business initiative. Lexaria has held a variety of discussions during 2025 – and expects this to intensify in 2026 – with a number of other pharmaceutical companies located in various jurisdictions around the world. DHT technology is not only being discussed within the GLP-1 drug sector, but also for other applications where Lexaria has completed previous investigatory work (e.g., for DHT-CBD for hypertension where we are ideally seeking to achieve strategic partner funding support for prospective future development activities of this Company asset), and even for brand-new drug sectors where DHT has never before been utilized. These discussions are being held with companies ranging in size from smaller regional companies up to and including some of the largest pharmaceutical companies in the world. $TEVA $JAZZ

0 · Reply

TheDudeRooster Mar. 13 at 6:53 PM

$TEVA Account looking sexy

0 · Reply

Terrordomo80 Mar. 13 at 2:59 PM

$TEVA Where my Bulltards @?

0 · Reply

Terrordomo80 Mar. 12 at 9:38 PM

$TEVA When you Hoped you'd be Wiser but unfortunately you are not... #Dopewiser #RidingTheSchvantz

0 · Reply

Terrordomo80 Mar. 12 at 4:18 PM

$TEVA ye ol shyt sangwich is back... for those who didnt take any off the table between 35 to 37...

0 · Reply

Market Cap	33.03B
Revenue (ttm)	17.26B
Net Income (ttm)	1.41B
EPS (ttm)	N/A
PE Ratio	10.48
Forward PE	11.14
Profit Margin	8.18%
Debt to Equity Ratio	2.12

Volume	6,292,900
Avg Vol	9,165,538
Day's Range	N/A - N/A
Shares Out	1.15B
Stochastic %K	10%
Beta	0.72
Analysts	Strong Sell
Price Target	$37.55